Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
31
FLMNF Quote, Financials, Valuation and Earnings
Last price:
$60.22
Seasonality move
:
-10.92%
Day range:
$60.22 - $60.22
52-week range:
$42.54 - $64.00
Dividend yield:
2.23%
P/E ratio:
27.40x
P/S ratio:
1.94x
P/B ratio:
4.80x
Volume:
--
Avg. volume:
3
1-year change:
41.57%
Market cap:
$5.1B
Revenue:
$2.4B
EPS (TTM):
$2.19
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
FLMNF
Fielmann Group AG
|
-- | -- | -- | -- | -- |
|
BNTX
BioNTech SE
|
$1.2B | $0.12 | -24.04% | -86.85% | $138.33 |
|
CVAC
CureVac NV
|
$25.1M | -$0.08 | 0.04% | -32.36% | $5.31 |
|
EVO
Evotec SE
|
$219.8M | -$0.01 | 17.8% | -75.1% | $5.4436 |
|
IFRX
InflaRx NV
|
$34.6K | -$0.14 | -74.55% | -16.09% | $11.24 |
|
IMTX
Immatics NV
|
$12.5M | -$0.45 | -81.87% | -704.25% | $18.75 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
FLMNF
Fielmann Group AG
|
$60.22 | -- | $5.1B | 27.40x | $1.34 | 2.23% | 1.94x |
|
BNTX
BioNTech SE
|
$94.52 | $138.33 | $22.7B | 191.55x | $0.00 | 0% | 6.43x |
|
CVAC
CureVac NV
|
$4.30 | $5.31 | $968.2M | 6.02x | $0.00 | 0% | 11.94x |
|
EVO
Evotec SE
|
$3.1100 | $5.4436 | $1.1B | -- | $0.00 | 0% | 1.33x |
|
IFRX
InflaRx NV
|
$1.10 | $11.24 | $74.5M | -- | $0.00 | 0% | 339.88x |
|
IMTX
Immatics NV
|
$10.22 | $18.75 | $1.2B | 42.21x | $0.00 | 0% | 13.65x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
FLMNF
Fielmann Group AG
|
-- | 1.345 | -- | 0.70x |
|
BNTX
BioNTech SE
|
1.31% | 1.267 | 1.22% | 6.78x |
|
CVAC
CureVac NV
|
3.87% | 1.835 | 3.39% | 1.84x |
|
EVO
Evotec SE
|
37.72% | 1.505 | 44.12% | 1.05x |
|
IFRX
InflaRx NV
|
2.1% | -0.453 | 1.26% | 2.34x |
|
IMTX
Immatics NV
|
3.78% | 2.023 | 1.86% | 6.97x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
FLMNF
Fielmann Group AG
|
$510.1M | $90.9M | 14.72% | 15.64% | 13.63% | -- |
|
BNTX
BioNTech SE
|
$1.6B | $743.4M | -2.96% | -3.01% | 41.89% | $785.5M |
|
CVAC
CureVac NV
|
$57.9M | -$11.6M | 19.52% | 20.55% | -18.33% | $31.6M |
|
EVO
Evotec SE
|
-$72.4K | -$59.7M | -11.62% | -17.7% | -31.17% | -$101.3M |
|
IFRX
InflaRx NV
|
-$89.2K | -$11.7M | -80.95% | -82.01% | -42057.91% | -$11.4M |
|
IMTX
Immatics NV
|
-- | -$63.9M | -24.18% | -25.21% | -1053.82% | -$56.2M |
Fielmann Group AG vs. Competitors
-
Which has Higher Returns FLMNF or BNTX?
BioNTech SE has a net margin of 8.77% compared to Fielmann Group AG's net margin of -1.89%. Fielmann Group AG's return on equity of 15.64% beat BioNTech SE's return on equity of -3.01%.
Company Gross Margin Earnings Per Share Invested Capital FLMNFFielmann Group AG81.76% $0.65 $1.1B BNTXBioNTech SE90.24% -$0.14 $22B -
What do Analysts Say About FLMNF or BNTX?
Fielmann Group AG has a consensus price target of --, signalling downside risk potential of --. On the other hand BioNTech SE has an analysts' consensus of $138.33 which suggests that it could grow by 46.35%. Given that BioNTech SE has higher upside potential than Fielmann Group AG, analysts believe BioNTech SE is more attractive than Fielmann Group AG.
Company Buy Ratings Hold Ratings Sell Ratings FLMNFFielmann Group AG0 0 0 BNTXBioNTech SE14 5 0 -
Is FLMNF or BNTX More Risky?
Fielmann Group AG has a beta of 0.418, which suggesting that the stock is 58.21% less volatile than S&P 500. In comparison BioNTech SE has a beta of 1.295, suggesting its more volatile than the S&P 500 by 29.477%.
-
Which is a Better Dividend Stock FLMNF or BNTX?
Fielmann Group AG has a quarterly dividend of $1.34 per share corresponding to a yield of 2.23%. BioNTech SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fielmann Group AG pays 63.5% of its earnings as a dividend. BioNTech SE pays out -- of its earnings as a dividend. Fielmann Group AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FLMNF or BNTX?
Fielmann Group AG quarterly revenues are $623.9M, which are smaller than BioNTech SE quarterly revenues of $1.8B. Fielmann Group AG's net income of $54.7M is higher than BioNTech SE's net income of -$33.5M. Notably, Fielmann Group AG's price-to-earnings ratio is 27.40x while BioNTech SE's PE ratio is 191.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fielmann Group AG is 1.94x versus 6.43x for BioNTech SE. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FLMNFFielmann Group AG1.94x 27.40x $623.9M $54.7M BNTXBioNTech SE6.43x 191.55x $1.8B -$33.5M
-
Which has Higher Returns FLMNF or CVAC?
CureVac NV has a net margin of 8.77% compared to Fielmann Group AG's net margin of -5832.47%. Fielmann Group AG's return on equity of 15.64% beat CureVac NV's return on equity of 20.55%.
Company Gross Margin Earnings Per Share Invested Capital FLMNFFielmann Group AG81.76% $0.65 $1.1B CVACCureVac NV91.57% $1.41 $1.1B -
What do Analysts Say About FLMNF or CVAC?
Fielmann Group AG has a consensus price target of --, signalling downside risk potential of --. On the other hand CureVac NV has an analysts' consensus of $5.31 which suggests that it could grow by 23.79%. Given that CureVac NV has higher upside potential than Fielmann Group AG, analysts believe CureVac NV is more attractive than Fielmann Group AG.
Company Buy Ratings Hold Ratings Sell Ratings FLMNFFielmann Group AG0 0 0 CVACCureVac NV1 3 0 -
Is FLMNF or CVAC More Risky?
Fielmann Group AG has a beta of 0.418, which suggesting that the stock is 58.21% less volatile than S&P 500. In comparison CureVac NV has a beta of 1.771, suggesting its more volatile than the S&P 500 by 77.063%.
-
Which is a Better Dividend Stock FLMNF or CVAC?
Fielmann Group AG has a quarterly dividend of $1.34 per share corresponding to a yield of 2.23%. CureVac NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fielmann Group AG pays 63.5% of its earnings as a dividend. CureVac NV pays out -- of its earnings as a dividend. Fielmann Group AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FLMNF or CVAC?
Fielmann Group AG quarterly revenues are $623.9M, which are larger than CureVac NV quarterly revenues of $63.3M. Fielmann Group AG's net income of $54.7M is lower than CureVac NV's net income of $319.3M. Notably, Fielmann Group AG's price-to-earnings ratio is 27.40x while CureVac NV's PE ratio is 6.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fielmann Group AG is 1.94x versus 11.94x for CureVac NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FLMNFFielmann Group AG1.94x 27.40x $623.9M $54.7M CVACCureVac NV11.94x 6.02x $63.3M $319.3M
-
Which has Higher Returns FLMNF or EVO?
Evotec SE has a net margin of 8.77% compared to Fielmann Group AG's net margin of -26.29%. Fielmann Group AG's return on equity of 15.64% beat Evotec SE's return on equity of -17.7%.
Company Gross Margin Earnings Per Share Invested Capital FLMNFFielmann Group AG81.76% $0.65 $1.1B EVOEvotec SE-0.04% -$0.14 $1.5B -
What do Analysts Say About FLMNF or EVO?
Fielmann Group AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Evotec SE has an analysts' consensus of $5.4436 which suggests that it could grow by 75.7%. Given that Evotec SE has higher upside potential than Fielmann Group AG, analysts believe Evotec SE is more attractive than Fielmann Group AG.
Company Buy Ratings Hold Ratings Sell Ratings FLMNFFielmann Group AG0 0 0 EVOEvotec SE1 0 0 -
Is FLMNF or EVO More Risky?
Fielmann Group AG has a beta of 0.418, which suggesting that the stock is 58.21% less volatile than S&P 500. In comparison Evotec SE has a beta of 1.821, suggesting its more volatile than the S&P 500 by 82.079%.
-
Which is a Better Dividend Stock FLMNF or EVO?
Fielmann Group AG has a quarterly dividend of $1.34 per share corresponding to a yield of 2.23%. Evotec SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fielmann Group AG pays 63.5% of its earnings as a dividend. Evotec SE pays out -- of its earnings as a dividend. Fielmann Group AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FLMNF or EVO?
Fielmann Group AG quarterly revenues are $623.9M, which are larger than Evotec SE quarterly revenues of $191.5M. Fielmann Group AG's net income of $54.7M is higher than Evotec SE's net income of -$50.3M. Notably, Fielmann Group AG's price-to-earnings ratio is 27.40x while Evotec SE's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fielmann Group AG is 1.94x versus 1.33x for Evotec SE. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FLMNFFielmann Group AG1.94x 27.40x $623.9M $54.7M EVOEvotec SE1.33x -- $191.5M -$50.3M
-
Which has Higher Returns FLMNF or IFRX?
InflaRx NV has a net margin of 8.77% compared to Fielmann Group AG's net margin of -51538.49%. Fielmann Group AG's return on equity of 15.64% beat InflaRx NV's return on equity of -82.01%.
Company Gross Margin Earnings Per Share Invested Capital FLMNFFielmann Group AG81.76% $0.65 $1.1B IFRXInflaRx NV-320.86% -$0.21 $54.4M -
What do Analysts Say About FLMNF or IFRX?
Fielmann Group AG has a consensus price target of --, signalling downside risk potential of --. On the other hand InflaRx NV has an analysts' consensus of $11.24 which suggests that it could grow by 922.16%. Given that InflaRx NV has higher upside potential than Fielmann Group AG, analysts believe InflaRx NV is more attractive than Fielmann Group AG.
Company Buy Ratings Hold Ratings Sell Ratings FLMNFFielmann Group AG0 0 0 IFRXInflaRx NV5 2 0 -
Is FLMNF or IFRX More Risky?
Fielmann Group AG has a beta of 0.418, which suggesting that the stock is 58.21% less volatile than S&P 500. In comparison InflaRx NV has a beta of 1.459, suggesting its more volatile than the S&P 500 by 45.896%.
-
Which is a Better Dividend Stock FLMNF or IFRX?
Fielmann Group AG has a quarterly dividend of $1.34 per share corresponding to a yield of 2.23%. InflaRx NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fielmann Group AG pays 63.5% of its earnings as a dividend. InflaRx NV pays out -- of its earnings as a dividend. Fielmann Group AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FLMNF or IFRX?
Fielmann Group AG quarterly revenues are $623.9M, which are larger than InflaRx NV quarterly revenues of $27.8K. Fielmann Group AG's net income of $54.7M is higher than InflaRx NV's net income of -$14.3M. Notably, Fielmann Group AG's price-to-earnings ratio is 27.40x while InflaRx NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fielmann Group AG is 1.94x versus 339.88x for InflaRx NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FLMNFFielmann Group AG1.94x 27.40x $623.9M $54.7M IFRXInflaRx NV339.88x -- $27.8K -$14.3M
-
Which has Higher Returns FLMNF or IMTX?
Immatics NV has a net margin of 8.77% compared to Fielmann Group AG's net margin of -974.45%. Fielmann Group AG's return on equity of 15.64% beat Immatics NV's return on equity of -25.21%.
Company Gross Margin Earnings Per Share Invested Capital FLMNFFielmann Group AG81.76% $0.65 $1.1B IMTXImmatics NV-- -$0.49 $508.8M -
What do Analysts Say About FLMNF or IMTX?
Fielmann Group AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Immatics NV has an analysts' consensus of $18.75 which suggests that it could grow by 83.46%. Given that Immatics NV has higher upside potential than Fielmann Group AG, analysts believe Immatics NV is more attractive than Fielmann Group AG.
Company Buy Ratings Hold Ratings Sell Ratings FLMNFFielmann Group AG0 0 0 IMTXImmatics NV9 0 0 -
Is FLMNF or IMTX More Risky?
Fielmann Group AG has a beta of 0.418, which suggesting that the stock is 58.21% less volatile than S&P 500. In comparison Immatics NV has a beta of 1.361, suggesting its more volatile than the S&P 500 by 36.134%.
-
Which is a Better Dividend Stock FLMNF or IMTX?
Fielmann Group AG has a quarterly dividend of $1.34 per share corresponding to a yield of 2.23%. Immatics NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fielmann Group AG pays 63.5% of its earnings as a dividend. Immatics NV pays out -- of its earnings as a dividend. Fielmann Group AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FLMNF or IMTX?
Fielmann Group AG quarterly revenues are $623.9M, which are larger than Immatics NV quarterly revenues of $6.1M. Fielmann Group AG's net income of $54.7M is higher than Immatics NV's net income of -$59.1M. Notably, Fielmann Group AG's price-to-earnings ratio is 27.40x while Immatics NV's PE ratio is 42.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fielmann Group AG is 1.94x versus 13.65x for Immatics NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FLMNFFielmann Group AG1.94x 27.40x $623.9M $54.7M IMTXImmatics NV13.65x 42.21x $6.1M -$59.1M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
